# A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects

> **NCT03197779** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 691 (actual)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** BMS-962212
- **DRUG:** Aspirin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03197779
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11-18
- **Primary completion:** 2016-02-02
- **Final completion:** 2017-01-24
- **Target enrollment:** 691 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03197779

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03197779, "A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03197779. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*